Dosing
Description:
Guidelines from Boston Medical Center designed for patient maintained on buprenorphine underdoing invasive procedures.
Source:
Colleen LaBelle, Boston Medical Center
Description:
This provides prescribing information for Suboxone sublingual film and includes information on indications, dosing, contraindications, adverse reactions, drug interactions and use in specific populations.
Source:
Reckitt Benckiser Pharmaceuticals
Description:
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
This article provides guidance on the management and treatment of acute pain in patients receiving buprenorphine/naloxone.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Logistics of buprenorphine treatment
- Addiction
- Dependence
- Discontinuation
- Dosing
- Induction
- Maintenance
- Methadone
- Pain
- Pharmacology
- Relapse
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
Buprenorphine tablets are approved for the treatment of opiate dependence. Buprenorphine treats opiate addiction by preventing symptoms of withdrawal from heroin and other opiates.
Source:
Food and Drug Administration (FDA)
Tags:
Description:
This abstract discusses a study done on the feasibility of an unobserved buprenorphine induction protocol. The study involved 103 patients who were heroin users and prescription opioid misusers, and discusses safety and rates of complications from induction through follow-up.
Source:
Journal of General Internal Medicine (2 votes)
Tags:
Description:
This is a basic form that helps physicians keep track of when and what quantity of buprenorphine they dispense.
Source:
American Academy of Addiction Psychiatry (AAAP) (3 votes)
Tags:
Description:
This form helps clinics keep a record of the drugs given out to each patient. This particular form has sections for date, patient's name, patient ID, dose, quantity dispensed, balance, manufacturer number, and patient's signature.
Source:
American Academy of Addiction Psychiatry (AAAP) (3 votes)
Tags:
Description:
Information on why your patient should be in withdrawal before beginning buprenorphine induction.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (3 votes)
Tags:
Description:
Discusses protocols for office-based buprenorphine treatment, including the administering of the drug itself, devising a treatment plan, and choosing an appropriate frequency for visits.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (4 votes)
Tags:
